BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sagris M, Vardas EP, Theofilis P, Antonopoulos AS, Oikonomou E, Tousoulis D. Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. Int J Mol Sci 2021;23:6. [PMID: 35008432 DOI: 10.3390/ijms23010006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kanorskii SG. Choice of sinus rhythm control strategy in patients with atrial fibrillation: why, when and how? A review. Vestnik aritmologii 2023;30:52-60. [DOI: 10.35336/va-2023-1-07] [Reference Citation Analysis]
2 Salis F, Palimodde A, Demelas G, Scionis MI, Mandas A. Frailty and comorbidity burden in Atrial Fibrillation. Front Public Health 2023;11. [DOI: 10.3389/fpubh.2023.1134453] [Reference Citation Analysis]
3 Kim AL, Musin EV, Oripova MJ, Oshchepkova YI, Salikhov SI, Tikhonenko SA. Polyelectrolyte Microcapsules-A Promising Target Delivery System of Amiodarone with the Possibility of Prolonged Release. Int J Mol Sci 2023;24. [PMID: 36834760 DOI: 10.3390/ijms24043348] [Reference Citation Analysis]
4 Zhong X, Jiao H, Zhao D, Yang M, Teng J. Association between serum uric acid levels and atrial fibrillation in different fasting glucose patterns: A case-control study. Front Endocrinol (Lausanne) 2023;14:1021267. [PMID: 36755929 DOI: 10.3389/fendo.2023.1021267] [Reference Citation Analysis]
5 Zhang X, Wei M, Bo Y, Song J, Yu Y, Zhou X, Tang B. Predictive value of neutrophil-to-apolipoprotein A1 ratio in all-cause and cardiovascular death in elderly non-valvular atrial fibrillation patients. Heliyon 2023;9:e12918. [PMID: 36820183 DOI: 10.1016/j.heliyon.2023.e12918] [Reference Citation Analysis]
6 Xu X, Zhang X, Cheng S, Ouyang M. Possible Protective Effects of Uridine on Atrial Fibrillation: A Mendelian Randomization Study.. [DOI: 10.21203/rs.3.rs-2436173/v1] [Reference Citation Analysis]
7 Aragón-Herrera A, Couselo-Seijas M, Feijóo-Bandín S, Anido-Varela L, Moraña-Fernández S, Tarazón E, Roselló-Lletí E, Portolés M, Martínez-Sande JL, García-Seara J, Álvarez E, González-Juanatey JR, Rodríguez-Mañero M, Eiras S, Lago F. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers. Sci Rep 2022;12:22287. [PMID: 36566255 DOI: 10.1038/s41598-022-26836-1] [Reference Citation Analysis]
8 Li T, Tong Q, Wang Z, Yang Z, Sun Y, Cai J, Xu Q, Lu Y, Liu X, Lin K, Qian Y. EGCG inhibits atrial fibrosis and reduces the occurrence and maintenance of atrial fibrillation and its possible mechanisms.. [DOI: 10.21203/rs.3.rs-2331153/v1] [Reference Citation Analysis]
9 Matsumori A. Management of Atrial Fibrillation Using Immunoglobulin Free Light Chains, Novel Biomarkers of Inflammation. Eur Cardiol 2022;17:e22. [PMID: 36643069 DOI: 10.15420/ecr.2022.30] [Reference Citation Analysis]
10 Li H, Song X, Liang Y, Bai X, Liu-Huo WS, Tang C, Chen W, Zhao L. Global, regional, and national burden of disease study of atrial fibrillation/flutter, 1990-2019: results from a global burden of disease study, 2019. BMC Public Health 2022;22:2015. [PMID: 36329400 DOI: 10.1186/s12889-022-14403-2] [Reference Citation Analysis]
11 Mlinar M, Katić Z. Invasive treatment of patients with atrial fibrillation and high risk of bleeding. Cardiologia Croatica 2022;17:309-309. [DOI: 10.15836/ccar2022.309] [Reference Citation Analysis]
12 Xu D, Xu C, Xue X, Xu Y, Zhao J, Huang T, Wang Z, Zhao Q, Zhou Z, Huang Y, Yu L, Wang H. Activation of cannabinoid receptor 2 attenuates Angiotensin II-induced atrial fibrillation via a potential NOX/CaMKII mechanism. Front Cardiovasc Med 2022;9:968014. [PMID: 36312282 DOI: 10.3389/fcvm.2022.968014] [Reference Citation Analysis]
13 Giannaki A, Sagris M, Toskas P, Antonopoulos AS, Oikonomou E, Theofilis P, Lazaros G, Tousoulis D. The Effect of Stress Management in Patients Post-acute Myocardial Infarction. Hellenic Journal of Cardiology 2022. [DOI: 10.1016/j.hjc.2022.10.005] [Reference Citation Analysis]
14 Theofilis P, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis K, Tousoulis D. Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives. Biomedicines 2022;10:2268. [DOI: 10.3390/biomedicines10092268] [Reference Citation Analysis]
15 Ionin VA, Zaslavskaya EL, Barashkova EI, Pavlova VA, Ananev AM, Morozov AN, Baranova EI. Predictors of atrial fibrillation recurrence in patients with metabolic syndrome after pulmonary vein isolation. Russ J Cardiol 2022;27:5184. [DOI: 10.15829/1560-4071-2022-5184] [Reference Citation Analysis]
16 Wang L, Sun H, Yang M, Xu Y, Hou L, Yu H, Wang X, Zhang Z, Han J. Bidirectional regulatory effects of Cordyceps on arrhythmia: Clinical evaluations and network pharmacology. Front Pharmacol 2022;13:948173. [DOI: 10.3389/fphar.2022.948173] [Reference Citation Analysis]
17 Tan Z, Song T, Huang S, Liu M, Ma J, Zhang J, Yu P, Liu X. Relationship between serum growth differentiation factor 15, fibroblast growth factor-23 and risk of atrial fibrillation: A systematic review and meta-analysis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.899667] [Reference Citation Analysis]
18 Yao Y, Yang M, Liu D, Zhao Q. Immune remodeling and atrial fibrillation. Front Physiol 2022;13:927221. [DOI: 10.3389/fphys.2022.927221] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Myers SJ, Jiménez-ruiz A, Sposato LA, Whitehead SN. Atrial cardiopathy and cognitive impairment. Front Aging Neurosci 2022;14:914360. [DOI: 10.3389/fnagi.2022.914360] [Reference Citation Analysis]
20 Fedai H, Altiparmak IH, Tascanov MB, Tanriverdi Z, Bicer A, Gungoren F, Demirbag R, Koyuncu I. The relationship between oxidative stress and autophagy and apoptosis in patients with paroxysmal atrial fibrillation. Scandinavian Journal of Clinical and Laboratory Investigation. [DOI: 10.1080/00365513.2022.2100274] [Reference Citation Analysis]
21 Ardahanli I, Ozkan HI. Comparison of Serum Selenium Levels Between Patients with Newly Diagnosed Atrial Fibrillation and Normal Controls. Biol Trace Elem Res. [DOI: 10.1007/s12011-022-03281-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Sagris M, Theofilis P, Antonopoulos AS, Oikonomou E, Tsioufis K, Tousoulis D. Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand? Biomedicines 2022;10:242. [PMID: 35203452 DOI: 10.3390/biomedicines10020242] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]